Strides Arcolab raising $274m for Australian acquisition
Syndication for a $274m loan for Indian pharmaceutical company Strides Arcolab is under way, with one lender at the helm. The proceeds are for the company’s acquisition of Aspen’s generic pharmaceutical business in Australia.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: